Erythropoietic protoporphyria. A clinical study based on 29 cases in 14 families.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D002769:Cholelithiasis / Q000150:complications; D004912:Erythrocytes / Q000378:metabolism*; D005243:Feces / Q000032:analysis; D005260:Female; D005796:Genes; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage; D007223:Infant; D007501:Iron / Q000097:blood; D008099:Liver / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009262:Nails / Q000473:pathology; D010375:Pedigree; D011164:Porphyrias / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D011166:Porphyrins / Q000032:analysis / Q000378:metabolism*; D011247:Pregnancy; D012075:Remission, Spontaneous; D012867:Skin / Q000473:pathology; D013057:Spectrum Analysis; D013256:Steroids / Q000008:administration & dosage; D014168:Transferrin / Q000032:analysis
D006454:Hemoglobins; D011166:Porphyrins; D013256:Steroids; D014168:Transferrin; D006886:Hydroxychloroquine; D007501:Iron